WO1991005536A3 - Novel oxidized lipoproteins and methods for their preparation - Google Patents
Novel oxidized lipoproteins and methods for their preparation Download PDFInfo
- Publication number
- WO1991005536A3 WO1991005536A3 PCT/US1990/005679 US9005679W WO9105536A3 WO 1991005536 A3 WO1991005536 A3 WO 1991005536A3 US 9005679 W US9005679 W US 9005679W WO 9105536 A3 WO9105536 A3 WO 9105536A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lipoproteins
- oxidized
- methods
- lipoprotein
- oxidize
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Lighting Device Outwards From Vehicle And Optical Signal (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR909007725A BR9007725A (en) | 1989-10-06 | 1990-10-04 | METHOD FOR THE PREPARATION OF OXIDIZED LIPOPROTEINS, METHOD FOR THE PREPARATION OF LOW DENSITY OXIDATED LIPOPROTEINS, COMPOSITION OF LOW DENSITY OXIDATED LIPOPROTEIN AND APPLIANCE FOR LIPOPROTEIN OXIDATION |
FI921430A FI921430A0 (en) | 1989-10-06 | 1992-04-01 | OXIDERAD LIPOPROTEIN OCH FOERFARANDE FOER DESS FRAMSTAELLNING. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41838289A | 1989-10-06 | 1989-10-06 | |
US418,382 | 1989-10-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1991005536A2 WO1991005536A2 (en) | 1991-05-02 |
WO1991005536A3 true WO1991005536A3 (en) | 1991-08-08 |
Family
ID=23657894
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1990/005679 WO1991005536A2 (en) | 1989-10-06 | 1990-10-04 | Novel oxidized lipoproteins and methods for their preparation |
PCT/US1990/005680 WO1991004744A1 (en) | 1989-10-06 | 1990-10-04 | Methods and apparatus for treating disease states using oxidized lipoproteins |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1990/005680 WO1991004744A1 (en) | 1989-10-06 | 1990-10-04 | Methods and apparatus for treating disease states using oxidized lipoproteins |
Country Status (7)
Country | Link |
---|---|
EP (2) | EP0494992A4 (en) |
JP (2) | JPH05500963A (en) |
AU (2) | AU7040091A (en) |
BR (2) | BR9007721A (en) |
CA (2) | CA2067364A1 (en) |
FI (2) | FI921430A0 (en) |
WO (2) | WO1991005536A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2674753B1 (en) * | 1991-04-02 | 1995-03-10 | Jean Berque | NEW THERAPEUTIC INDICATIONS, PARTICULARLY FOR THE TREATMENT OF AIDS, OF AN ALREADY EXISTING MEDICINAL PRODUCT FROM A DENIMOUS MOLECULE OF CONTRAINDICATIONS AND ADVERSE REACTIONS. |
WO1994023302A1 (en) * | 1993-04-07 | 1994-10-13 | The Australian National University | Immunological assay of oxidatively modified human low density lipoproteins in plasma |
PT1328289E (en) * | 2000-10-20 | 2008-12-10 | Hamburger Stiftung Zur Foerder | Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof |
AU2003232209A1 (en) * | 2003-04-25 | 2004-11-23 | Hamburger Stiftung Zur Forderung Von Wissenschaft Und Kultur | Treatment of hi-virus infections with oxidised blood proteins |
WO2006059082A1 (en) * | 2004-11-30 | 2006-06-08 | Trigen Limited | Oxidised lipids as reversal agents for boronic acid drugs |
US9551768B2 (en) | 2013-03-15 | 2017-01-24 | East Carolina University | NMR method for monitoring changes in the core of lipoprotein particles in metabolism and disease |
US10775458B2 (en) | 2018-03-05 | 2020-09-15 | Texas Tech University System | Method and system for non-invasive measurement of metabolic health |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2095388A (en) * | 1935-08-03 | 1937-10-12 | Bendix Radio Corp | Electrical regulator apparatus |
US2095338A (en) * | 1927-08-20 | 1937-10-12 | Ig Farbenindustrie Ag | Process for oxidizing organic substances in the liquid phase and apparatus therefor |
US3655700A (en) * | 1970-02-02 | 1972-04-11 | Zoecon Corp | Oxygenated unsaturated aliphatic carboxylic acids and esters |
US4226713A (en) * | 1978-04-24 | 1980-10-07 | Goldberg Jack M | Diagnostic agents |
US4472303A (en) * | 1981-07-10 | 1984-09-18 | Kuraray Co., Ltd. | Blood purification method |
DD243714A1 (en) * | 1985-10-08 | 1987-03-11 | Akad Wissenschaften Ddr | PROCESS FOR STABILIZING IMMOBILIZED GLUCOSE OXIDASE |
-
1990
- 1990-10-04 CA CA002067364A patent/CA2067364A1/en not_active Abandoned
- 1990-10-04 AU AU70400/91A patent/AU7040091A/en not_active Abandoned
- 1990-10-04 EP EP19900916422 patent/EP0494992A4/en not_active Withdrawn
- 1990-10-04 CA CA002067356A patent/CA2067356A1/en not_active Abandoned
- 1990-10-04 BR BR909007721A patent/BR9007721A/en not_active Application Discontinuation
- 1990-10-04 JP JP3502153A patent/JPH05500963A/en active Pending
- 1990-10-04 EP EP19910901910 patent/EP0495014A4/en not_active Withdrawn
- 1990-10-04 JP JP2515223A patent/JPH05501258A/en active Pending
- 1990-10-04 WO PCT/US1990/005679 patent/WO1991005536A2/en not_active Application Discontinuation
- 1990-10-04 WO PCT/US1990/005680 patent/WO1991004744A1/en not_active Application Discontinuation
- 1990-10-04 AU AU70452/91A patent/AU7045291A/en not_active Abandoned
- 1990-10-04 BR BR909007725A patent/BR9007725A/en not_active Application Discontinuation
-
1992
- 1992-04-01 FI FI921430A patent/FI921430A0/en not_active Application Discontinuation
- 1992-04-01 FI FI921431A patent/FI921431A/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2095338A (en) * | 1927-08-20 | 1937-10-12 | Ig Farbenindustrie Ag | Process for oxidizing organic substances in the liquid phase and apparatus therefor |
US2095388A (en) * | 1935-08-03 | 1937-10-12 | Bendix Radio Corp | Electrical regulator apparatus |
US3655700A (en) * | 1970-02-02 | 1972-04-11 | Zoecon Corp | Oxygenated unsaturated aliphatic carboxylic acids and esters |
US4226713A (en) * | 1978-04-24 | 1980-10-07 | Goldberg Jack M | Diagnostic agents |
US4472303A (en) * | 1981-07-10 | 1984-09-18 | Kuraray Co., Ltd. | Blood purification method |
DD243714A1 (en) * | 1985-10-08 | 1987-03-11 | Akad Wissenschaften Ddr | PROCESS FOR STABILIZING IMMOBILIZED GLUCOSE OXIDASE |
Non-Patent Citations (10)
Title |
---|
DIXON et al Enzymes (1979 Academic Prss, New York) p. 740-741, enzymes 1.11.1.3 and 1.11.1.7. * |
GARNER, CHEMICAL ABSTRACTS 1-12 Volum 102, 1985 Abstract 42042 39. * |
GARNER, CHEMICAL ABSTRACTS, Vol. 102, 1985 Abstract 42042. * |
LUTHER, et al 12 October 1937 (Entire document). * |
POKORNY et al CHEMICAL ABSTRACTS, Vol. 78, 1973 Abstract 39713V. * |
See also references of EP0495014A4 * |
Wako Pure Chemical, CHEMICAL ABSTRACTS Vol. 95, 1981, Abstract 128864p. * |
Wako Pure Chemicals. CHEMICAL ABSTRACTS, Vol. 95, 1981 Abstract 128864P. * |
YOSHIOKA et al, CHEMICAL ABSTRACTS Vol. 97, 1982 Abstract 160247. * |
YOSHIOTIA, et al CHEMICAL ABSTRACTS Vol. 97, 1982 Abstract 160240j. * |
Also Published As
Publication number | Publication date |
---|---|
CA2067356A1 (en) | 1991-04-07 |
FI921431A0 (en) | 1992-04-01 |
FI921431A (en) | 1992-04-01 |
FI921430A (en) | 1992-04-01 |
JPH05500963A (en) | 1993-02-25 |
WO1991005536A2 (en) | 1991-05-02 |
AU7045291A (en) | 1991-05-16 |
FI921430A0 (en) | 1992-04-01 |
AU7040091A (en) | 1991-04-28 |
WO1991004744A1 (en) | 1991-04-18 |
CA2067364A1 (en) | 1991-04-07 |
BR9007721A (en) | 1992-08-18 |
BR9007725A (en) | 1992-08-18 |
EP0494992A1 (en) | 1992-07-22 |
EP0495014A1 (en) | 1992-07-22 |
EP0494992A4 (en) | 1993-03-31 |
JPH05501258A (en) | 1993-03-11 |
EP0495014A4 (en) | 1993-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0116376B1 (en) | perfume composition, consumer product, tissue treatment, personal care, hard surface treatment and air treatment compositions, and non-therapeutic method to provide positive mood benefits, particularly relaxation benefits, to an individual . | |
CA2395674A1 (en) | Methods and compositions for reconstruction of multilayered tissue structures | |
CA2286655A1 (en) | Tissue decellularization | |
ES2182869T3 (en) | SACARIDO NO REDUCTOR AND ITS USE. | |
MXPA01008125A (en) | Composition for the oxidation dyeing of keratinous fibers comprising at least one oxidation dye and at least one cationic amphiphilic polymer, and dyeing methods. | |
EP2277992A3 (en) | Progenitor cells from Wharton's jelly of human umbilical cord | |
GB2331015A (en) | Therapeutic methods and compositions involving isoflavones | |
BRPI0413241A (en) | monatin table sweetener compositions and methods of making the same | |
CA2053258A1 (en) | Use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorption | |
NZ229212A (en) | Heparin derivatives and preparation | |
MXPA03011176A (en) | Pseudoplastic, film forming cosmetic compositions. | |
WO1991005536A3 (en) | Novel oxidized lipoproteins and methods for their preparation | |
CA2099356A1 (en) | Hydroxylated Milk Glycerides | |
DE59913103D1 (en) | SUBSTITUTED 4-AMINO-2-ARYL-CYCLOPENTA ÄDÜPYRIMIDINE, THEIR PREPARATION, THEIR USE AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
EP0824910A3 (en) | Use of a Krill Enzyme for the Treatment of Dental Plaque | |
EP0117070A3 (en) | Cosmetic sticks | |
FR2792831A1 (en) | COMPOSITION FOR COSMETIC AND / OR DIETETIC USE COMPRISING A MIXTURE OF LYCOPENE AND OLIVE LEAF EXTRACT | |
JPS6438007A (en) | Skin external preparation | |
GB8704904D0 (en) | Composition | |
ES2116496T3 (en) | PROCESS FOR THE PREPARATION OF 1,4-DISUBSTITUTED-5 (4H) -TETRAZOLINONES. | |
CA2332532A1 (en) | Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells | |
SE8800176L (en) | ANTI-INFLAMMATORALLY OXIDATING AGENTS, PROCEDURES FOR PREPARING THEREOF, AND APPLICATION THEREOF | |
AU3155701A (en) | Method and compositions for producing cell transplants | |
CA2073453A1 (en) | Methods of enhancing wound healing and tissue repair | |
ATE204766T1 (en) | SYNTHETIC TRIGLYCERIDE FEELING FOR SURGICALLY IMPLANTED PROSTHESES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BR CA FI JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BR CA FI JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE |
|
WR | Later publication of a revised version of an international search report | ||
WR | Later publication of a revised version of an international search report | ||
WWE | Wipo information: entry into national phase |
Ref document number: 921430 Country of ref document: FI |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2067364 Country of ref document: CA Ref document number: 1991901910 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1991901910 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1991901910 Country of ref document: EP |